Treating Peanut Allergies With Oral Immunotherapies

The video explores the global business of pharmaceuticals, focusing on the rise of peanut allergies and the use of oral immunotherapy (OIT) as a treatment. Despite its effectiveness, OIT faces challenges in gaining FDA approval. The video also compares OIT with a peanut patch treatment and discusses new studies on early allergen introduction. Investor concerns about stock performance in the biopharmaceutical sector are also addressed.

What percentage increase in food allergies among children was observed between 1997 and 2011?

• 90%

• 70%

• 50%

• 30%

What is the main component used in oral immunotherapy for peanut allergies?

• Peanut oil

• Peanut extract

• Peanut butter

• Peanut flour

Why is the FDA hesitant to approve oral immunotherapy?

• Unproven effectiveness

• Need for formal approval in controlled trials

• Lack of clinical trials

• High cost of treatment

What is one advantage of the oral immunotherapy approach over the peanut patch?

• Easier administration

• Lower cost

• Faster results

• Fewer side effects

What is a recommended strategy for tackling food allergies early in children?

• Consulting a nutritionist

• Introducing peanuts in the first year of life

• Using allergy medications

• Avoiding all nuts